151 related articles for article (PubMed ID: 15358116)
1. The secretable form of trimeric TRAIL, a potent inducer of apoptosis.
Kim MH; Billiar TR; Seol DW
Biochem Biophys Res Commun; 2004 Sep; 321(4):930-5. PubMed ID: 15358116
[TBL] [Abstract][Full Text] [Related]
2. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
3. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein.
Wu X; He Y; Falo LD; Hui KM; Huang L
Mol Ther; 2001 Mar; 3(3):368-74. PubMed ID: 11273779
[TBL] [Abstract][Full Text] [Related]
4. Cysteine 230 modulates tumor necrosis factor-related apoptosis-inducing ligand activity.
Seol DW; Billiar TR
Cancer Res; 2000 Jun; 60(12):3152-4. PubMed ID: 10866303
[TBL] [Abstract][Full Text] [Related]
5. Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins.
Hu B; Zhu H; Qiu S; Su Y; Ling W; Xiao W; Qi Y
Biochem Biophys Res Commun; 2004 Dec; 325(4):1153-62. PubMed ID: 15555548
[TBL] [Abstract][Full Text] [Related]
6. Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
Wenger T; Mattern J; Penzel R; Gassler N; Haas TL; Sprick MR; Walczak H; Krammer PH; Debatin KM; Herr I
Cell Death Differ; 2006 Oct; 13(10):1740-51. PubMed ID: 16470224
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
[TBL] [Abstract][Full Text] [Related]
8. [Expression of TRAIL(114-281) mediated by adeno-associated virus and its tumoricidal activity].
Ma H; Liu YX; Liu SL; Xu RA; Zheng DX
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1635-41. PubMed ID: 15569460
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
Mori T; Doi R; Toyoda E; Koizumi M; Ito D; Kami K; Kida A; Masui T; Kawaguchi Y; Fujimoto K
Surgery; 2005 Jul; 138(1):71-7. PubMed ID: 16003319
[TBL] [Abstract][Full Text] [Related]
10. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
Ma H; Liu Y; Liu S; Xu R; Zheng D
Hepatology; 2005 Dec; 42(6):1355-63. PubMed ID: 16317690
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
[TBL] [Abstract][Full Text] [Related]
12. [Expression of Trial in mammalian cell and its apoptosis activation in culture cells].
Yao YC; Wang XM; Hu YP
Yi Chuan Xue Bao; 2001 May; 28(5):482-6. PubMed ID: 11441662
[TBL] [Abstract][Full Text] [Related]
13. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
[TBL] [Abstract][Full Text] [Related]
14. Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.
Di Pietro R; Zauli G
J Cell Physiol; 2004 Dec; 201(3):331-40. PubMed ID: 15389537
[TBL] [Abstract][Full Text] [Related]
15. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
[TBL] [Abstract][Full Text] [Related]
16. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
17. [Action of apoptosis-induced ligand gene in relation to tumor necrosis factor on human colon cancer cell line HT29].
He C; Hu X; Xu X; Fang B
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):133-6. PubMed ID: 12015033
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of tumour necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL): cysteine-230 plays a critical role in the homotrimerization and biological activity of this novel tumoricidal cytokine.
Trabzuni D; Famulski KS; Ahmad M
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):505-10. PubMed ID: 10947965
[TBL] [Abstract][Full Text] [Related]
20. [Expression and biological activities of TRAIL fusion protein gene].
Li J; Zheng Y; Chen H; Du L; Shu CL; Cheng Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):535-7. PubMed ID: 15182642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]